Christopher Peetz
Chief Executive Officer, Director at Mirum Pharmaceuticals, Inc. (MIRM)
Christopher Peetz has filed 55 insider reports with the SEC since May 2021, as chief Executive Officer and director at Mirum Pharmaceuticals, Inc. (MIRM), director at Arcutis Biotherapeutics, Inc. (ARQT) and director at Alpine Immune Sciences, Inc. (ALPN). In the last 12 months Christopher Peetz sold $18.1M of stock on the open market. On November 4, 2026 Christopher Peetz filed a Form 144 notice and plans to sell 20,000 MIRM shares (~$1.8M). In the latest filing, on November 5, 2026, Christopher Peetz sold 20,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $1.8M at an average of $90.00.
Planned sale (Form 144)
- Christopher Peetz plans to sell 20,000 MIRM shares (~$1.8M), around Nov 4, 2026. Notice filed Nov 4, 2026.
A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.
- Filings
- 55
- Companies
- 3
- Bought on market
- $120K
- Sold on market
- $27.6M
Companies where Christopher Peetz is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officer, Director | 206,637 | $101K | $27.6M | $14.40 | $92.49+542% | Nov 5, 2026 | |
| Directorsince July 2026 | 4,315 | $27.61 | Jul 17, 2026 | ||||
| Director | $19.3K | $10.17 | May 21, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 4, 2026-$1.8MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 20,000 shares at a strike of $2.94 and sold $1,800,000 worth of shares (20,000 units at $90.00) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 4, 2026~$1.8MMIRMChristopher Peetz plans to sell 20,000 shares (~$1.8M)Form 144Planned sale10b5-1 plan
- Sep 1, 2026-$2.96MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 30,000 shares at a strike of $2.94 and sold $2,960,401 worth of shares (30,000 units at $98.68) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 1, 2026~$2.96MMIRMChristopher Peetz plans to sell 30,000 shares (~$2.96M)Form 144Planned sale10b5-1 plan
- Aug 10, 2026-$1.98MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher sold $1,978,402 worth of shares (20,000 units at $98.92) as part of a pre-agreed trading plan and exercised 20,000 shares at a strike of $2.94Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 10, 2026~$1.98MMIRMChristopher Peetz plans to sell 20,000 shares (~$1.98M)Form 144Planned sale10b5-1 plan
- Jul 15, 2026ARQTDirector Peetz Christopher was granted 4,315 sharesForm 4Grant or award
- Jul 15, 2026ARQTNew insider Peetz Christopher claimed ownership of 187,500 sharesForm 3New insider
- Jul 6, 2026-$2.45MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 20,000 shares at a strike of $2.94 and sold $2,445,382 worth of shares (20,000 units at $122.27) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 6, 2026~$2.45MMIRMChristopher Peetz plans to sell 20,000 shares (~$2.45M)Form 144Planned sale10b5-1 plan
- Jun 1, 2026-$2.88MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 30,000 shares at a strike of $2.94 and sold $2,875,103 worth of shares (30,000 units at $95.84) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 1, 2026~$2.88MMIRMChristopher Peetz plans to sell 30,000 shares (~$2.88M)Form 144Planned sale10b5-1 plan
- Mar 16, 2026-$3.77MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher converted options into 75,000 shares and sold $3,769,714 worth of shares (40,985 units at $91.98), increasing direct ownership by 21% to 194,309 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Mar 17, 2026~$3.8MMIRMChristopher Peetz plans to sell 40,985 shares (~$3.8M)Form 144Planned sale10b5-1 plan
- Feb 2, 2026-$941KMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher sold $940,888 worth of shares (9,108 units at $103.30), decreasing direct ownership by 5% to 160,294 unitsForm 4Open-market sale
- Feb 2, 2026~$945KMIRMChristopher Peetz plans to sell 9,108 shares (~$945K)Form 144Planned sale10b5-1 plan
- Jan 28, 2026MIRMSEC Form 4 filed by CHIEF EXECUTIVE OFFICER Peetz ChristopherForm 4Grant or award
- Jan 28, 2026~$662KMIRMChristopher Peetz plans to sell 6,831 shares (~$662K)Form 144Planned sale10b5-1 plan
- Jan 26, 2026-$657KMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher converted options into 12,500 shares and sold $657,088 worth of shares (6,831 units at $96.19), increasing direct ownership by 3% to 169,402 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Jan 22, 2026-$662KMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher converted options into 12,797 shares and sold $662,422 worth of shares (7,098 units at $93.33), increasing direct ownership by 4% to 163,733 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Dec 31, 2025MIRMCHIEF EXECUTIVE OFFICER Peetz Christopher gifted 21,070 sharesForm 4Gift
- Nov 18, 2025MIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 19,133 shares at a strike of $19.24, increasing direct ownership by 14% to 158,034 unitsForm 4Exercise or conversion of a derivative
- Aug 11, 2025-$2.48MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 40,000 shares at a strike of $2.94 and sold $2,480,000 worth of shares (40,000 units at $62.00)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 11, 2025~$2.48MMIRMChristopher Peetz plans to sell 40,000 shares (~$2.48M)Form 144Planned sale10b5-1 plan
- Aug 7, 2025-$2.21MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 40,000 shares at a strike of $2.94 and sold $2,210,040 worth of shares (40,000 units at $55.25)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 7, 2025~$2.21MMIRMChristopher Peetz plans to sell 40,000 shares (~$2.21M)Form 144Planned sale10b5-1 plan
- Mar 17, 2025-$1.21MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher converted options into 50,000 shares and sold $1,206,122 worth of shares (27,279 units at $44.21), increasing direct ownership by 20% to 138,641 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Mar 3, 2025-$1.88MMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 40,000 shares at a strike of $2.94 and sold $1,876,353 worth of shares (40,000 units at $46.91)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 3, 2025~$1.88MMIRMChristopher Peetz plans to sell 40,000 shares (~$1.88M)Form 144Planned sale10b5-1 plan
- Feb 3, 2025-$439KMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher sold $438,921 worth of shares (9,102 units at $48.22), decreasing direct ownership by 7% to 115,920 unitsForm 4Open-market sale
- Jan 24, 2025-$328KMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher converted options into 12,500 shares and sold $327,658 worth of shares (6,837 units at $47.92), increasing direct ownership by 5% to 125,022 unitsForm 4Exercise or conversion of a derivativeOpen-market sale
- Jan 21, 2025MIRMSEC Form 4 filed by CHIEF EXECUTIVE OFFICER Peetz ChristopherForm 4Grant or award
- Jan 7, 2025-$321KMIRMCHIEF EXECUTIVE OFFICER Peetz Christopher sold $320,644 worth of shares (7,489 units at $42.82), decreasing direct ownership by 6% to 119,359 unitsForm 4Open-market sale
- Nov 8, 2024MIRMCHIEF EXECUTIVE OFFICER Peetz Christopher was granted 65 shares, increasing direct ownership by 0.05% to 126,848 unitsForm 4Grant or award
- Jul 23, 2024MIRMCHIEF EXECUTIVE OFFICER Peetz Christopher exercised 34,013 shares at a strike of $2.94, increasing direct ownership by 37% to 126,783 unitsForm 4Exercise or conversion of a derivative
- May 20, 2024ALPNPeetz Christopher returned 1,900 shares to the companyForm 4Sale back to the company
- May 10, 2024MIRMPeetz Christopher was granted 817 shares, increasing direct ownership by 0.89% to 92,770 unitsForm 4Grant or award
- Jan 9, 2023-$106KMIRMPeetz Christopher sold $106,390 worth of shares (5,159 units at $20.62), decreasing direct ownership by 5% to 91,953 unitsForm 4Open-market sale
- Feb 2, 2024-$157KMIRMPeetz Christopher sold $157,491 worth of shares (6,013 units at $26.19), decreasing direct ownership by 5% to 104,112 unitsForm 4Open-market sale
- Jan 23, 2024MIRMSEC Form 4 filed by Peetz ChristopherForm 4Grant or award
- Jan 8, 2024-$146KMIRMPeetz Christopher sold $146,033 worth of shares (5,209 units at $28.03), decreasing direct ownership by 5% to 110,125 unitsForm 4Open-market sale
- Jan 2, 2024ALPNSEC Form 4 filed by Peetz ChristopherForm 4Grant or award
- Jul 3, 2023-$141KMIRMSEC Form 4 filed by Peetz ChristopherForm 4Open-market sale
- May 10, 2023MIRMSEC Form 4 filed by Peetz ChristopherForm 4Grant or award
- Jan 31, 2023MIRMSEC Form 4: Peetz Christopher was granted 50,000 shares, increasing direct ownership by 72% to 119,576 unitsForm 4Grant or award
- Jan 3, 2023ALPNSEC Form 4 filed by Peetz ChristopherForm 4Grant or award
- Nov 10, 2022MIRMSEC Form 4: Peetz Christopher was granted 49 shares, increasing direct ownership by 0.07% to 69,576 unitsForm 4Grant or award
- May 10, 2022MIRMSEC Form 4: Peetz Christopher was granted 1,500 shares, increasing direct ownership by 2% to 69,527 unitsForm 4Grant or award
- Jan 6, 2022MIRMSEC Form 4: Peetz Christopher was granted 40,000 shares, increasing direct ownership by 143% to 68,027 unitsForm 4Grant or award
- Jan 3, 2022ALPNSEC Form 4 filed by Peetz ChristopherForm 4Grant or award
- Nov 24, 2021+$101KMIRMSEC Form 4: Peetz Christopher bought $100,800 worth of shares (7,000 units at $14.40), increasing direct ownership by 33% to 28,027 unitsForm 4Open-market purchase
- Oct 1, 2021-$70.7KMIRMSEC Form 4: Peetz Christopher was granted 21,875 shares and sold $70,708 worth of shares (3,672 units at $19.26), increasing direct ownership by 645% to 21,027 units (withholding obligation)Form 4Grant or awardOpen-market sale
- Sep 23, 2021+$19.3KALPNSEC Form 4: Peetz Christopher bought $19,323 worth of shares (1,900 units at $10.17) (Amendment)Form 4Open-market purchase
- Sep 23, 2021ALPNSEC Form 4 filed by Peetz ChristopherForm 4Open-market sale
- May 10, 2021MIRMSEC Form 4: Peetz Christopher was granted 1,453 units of Common STock, increasing direct ownership by 106% to 2,824 unitsForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Christopher Peetz.
Compare Christopher Peetz with
- Christopher Peetz vs Patrick J Heron2 shared
- Christopher Peetz vs Howard G. Welgus1 shared
- Christopher Peetz vs Saira Ramasastry1 shared
- Christopher Peetz vs Todd Watanabe1 shared
- Christopher Peetz vs Laura Brege1 shared
- Christopher Peetz vs Joanne Quan1 shared
Other insiders at the same companies
- Howard G. WelgusARQT
- Saira RamasastryMIRM
- Todd WatanabeARQT
- Laura BregeMIRM
- Joanne QuanMIRM
- Masaru MatsudaARQT
- Robert LisickiARQT
- Robert A ScottARQT
- Patrick BurnettARQT
- Robert Paul MyersMIRM
- Eric BjerkholtMIRM
- Jolanda HoweMIRM
- Terrie CurranARQT
- Sue-Jean LinARQT
- Timothy P WalbertMIRM
- Lon CardonMIRM
Questions about Christopher Peetz
- What is Christopher Peetz's role at Mirum Pharmaceuticals, Inc.?
- Christopher Peetz reports to the SEC as chief Executive Officer and director at Mirum Pharmaceuticals, Inc. (MIRM), according to the latest filing on November 5, 2026. Christopher Peetz has also filed as director at Arcutis Biotherapeutics, Inc. (ARQT) and director at Alpine Immune Sciences, Inc. (ALPN).
- How many shares does Christopher Peetz own?
- After the latest filing that states it, Christopher Peetz directly owned 206,637 shares of Mirum Pharmaceuticals, Inc. (MIRM) and 4,315 shares of Arcutis Biotherapeutics, Inc. (ARQT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Christopher Peetz bought or sold stock recently?
- The most recent open-market purchase was on November 24, 2021: bought 7,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $101K at an average of $14.40. The most recent open-market sale was on November 4, 2026: sold 20,000 shares of Mirum Pharmaceuticals, Inc. (MIRM) for $1.8M at an average of $90.00.
- How do I get alerts when Christopher Peetz files?
- Follow Christopher Peetz on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Christopher Peetz filed 4 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Christopher Peetz (SEC CIK 0001614740). Totals count each trade once, skipping amendments whose original is on file, from May 12, 2021 on. View on SEC EDGAR